96708 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
#3022-Azetidinone Derivatives For The Treatment Of Hyperlipidaemic Diseases
#303Chemical linkers and cleavable substrates and conjugates thereof
#304Compounds for enzyme inhibition
#305Compounds for enzyme inhibition
#306DIMERIC IAP INHIBITORS
#307Influenza infection-inhibiting peptide, influenza virus infection inhibitor, liposome, and influenza preventive/therapeutic agent
#308Targeted delivery to legumain-expressing cells
#309HCV NS3 Protease Inhibitors
#310SMAC Peptidomimetics and the Uses Thereof
#311HCV protease inhibitors and uses thereof
#312Peptides Inhibiting Angiotensin-Converting Enzyme
#313New 2-Azetidinone Derivatives As Cholesterol Absorption Inhibitors For The Treatment Of Hyperlipidaemic Conditions
#314New 2-Azetidinone Derivatives Useful In The Treatment Of Hyperlipidaemic Conditions
#315HCV protease inhibitors and uses thereof
#316HCV protease inhibitors and uses thereof
#317Macrocyclic compounds as antiviral agents
#318HCV protease inhibitors and uses thereof
#319Macrocyclic hepatitis C serine protease inhibitors
#320IMMUNOMODULATORY DAIRY PEPTIDES AND USES THEREOF
#321Cross-linkers and their uses
#322Hepatitis C virus inhibitors
#323Macrocyclic compounds as antiviral agents
#324Reagents and methods for smooth muscle therapies
#325Selective substrates for matrix metalloproteinases
#326Process for preparing peptide products for promoting cholecystokinin secretion and use of the peptide products
#327Methods and uses for protein breakdown products
#328Solution Synthesis of Peptide Cell Growth Stimulators
#329COMPOUNDS FOR ENZYME INHIBITION
#330Compounds for enzyme inhibition
#331POLYOXYALKYLENE CHAIN-CONTAINING LIPID DERIVATIVE AND LIPID FILM STRUCTURE CONTAINING SUCH DERIVATIVE
#332NOVEL PEPTIDES FOR TREATING AND PREVENTING IMMUNE-RELATED DISORDERS, INCLUDING TREATING AND PREVENTING INFECTION BY MODULATING INNATE IMMUNITY
#333HCV protease inhibitors and uses thereof
#334Reagents and Methods for Smooth Muscle Therapies
#335Reagents and methods for smooth muscle therapies
#336Inhibiting tumor cell invasion, metastasis and angiogenesis
#337NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
#338Methods for the treatment or prevention of scars and/or keloids
#339Methionine aminopeptidase-2 inhibitors and methods of use thereof
#340Novel Macrocyclic Inhibitors of Hepatitis C Virus Replication
#341Biologically active C-terminal arginine-containing peptides
#342Therapeutic fibrin-derived peptides and uses thereof
#343Methods and compositions for increasing skin remodeling
#344Topical application agents against mimic and age-related wrinkles
#345Anti-cancer compounds
#346Therapeutic fibrin-derived peptides and uses thereof
#347HCV NS3 protease inhibitors
#348Method of producing peptide
#349Amide forming chemical ligation
#350Organic compounds
#351Method for preparing analysis sample, analysis sample and sugar chain capture agent
#352Methods for the directed expansion of epitopes for use as antibody ligands
#353Peptides Capable of Functioning as Mimotopes for Hormonal Analytes
#354Process for Production of (1,3-Disubstituted Indolyl)-Urea Derivatives, Intermediates Therefor, and Process for Production of the Intermediates
#355PAR-2 antagonists
#356Novel Molecular Probes
#357Triazole-containing releasable linkers, conjugates thereof, and methods of preparation
#358Immunoregulatory compositions
#359BIOLOGICALLY ACTIVE PEPTIDES
#360Asymmetric synthesis of peptides
#361Conformationally constrained Smac mimetics and the uses thereof
#362Thyrotropin-Releasing Hormone Analogs and Method of Use
#363Peptide compositions
#364Prodrugs of Phentermine
#365Biologically active peptide consisting of tyrosyl-seryl-leucine (YSL)
#366Biologically active peptides and their new uses
#3672-aminocarbonyl substituted piperazine or diaza-cyclic compounds as apoptosis protein inhibitors (lap) modulators
#368IAP BIR domain binding compounds
#369Peptides derived from human BPLP protein
#370Gene regulator
#371Treatment of burns
#372Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
#373Fc receptor modulating compounds and compositions
#374Methods for designing and synthesizing directed sequence polymer compositions via the directed expansion of epitope permeability
#375Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
#376Catalytically active recombinant memapsin and methods of use thereof
#377ABUSE-RESISTANT HYDROCODONE COMPOUNDS, COMPOSITIONS AND METHODS OF USING THE SAME
#378IMMUNOREGULATORY COMPOSITIONS
#379IAP BIR domain binding compounds
#380Inhibitors of Memapsin 2 and use thereof
#381IAP BIR domain binding compounds
#382Inhibitors of IAP
#383Compounds for enzyme inhibition
#384Compounds and compositions as channel activating protease inhibitors
#385Compounds and compositions as channel activating protease inhibitors
#386Amino Acid Sequences Essential to Neuron Specific Gene Expression
#387Biologically active peptide PTTKTYFPHF
#388Biologically Active Peptides
#389IAP BIR domain binding compounds
#390Compositions capable of reducing elevated blood urea concentration
#391Solution Synthesis of Peptide Cell Growth Stimulators
#392Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels
#393Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful for treating aids
#394Antifusogenic proteins comprising human immunodeficiency virus type 1 (HIV-1) gp41 DP-178 polypeptide variants and a macromolecular carrier
#395Osteogenic proteins
#396Therapeutic agents and methods of use thereof for the modulation of angiogenesis
#397Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
#398Compounds for enzyme inhibition
#399IAP BIR domain binding compounds
#400IAP BIR domain binding compounds
#401Vitamin C derivatives with peptide, preparation method thereof and composition comprising the same
#402Peptides for enhanced cell attachment and growth
#403Amide forming chemical ligation
#404Treatment of ischemic events
#405Macrocyclic inhibitors of hepatitis C virus replication
#406Mass tags for quantitative analyses
#407Therapeutic fibrin-derived peptides and uses thereof
#408Molecules that block viral infectivity and methods of use thereof
#409Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission
#410Methionine aminopeptidase-2 inhibitors and methods of use thereof
#411Method of treating interferon non-responders using HCV protease inhibitor
#412Asymmetric dosing methods
#413Biologically active peptides
#414Fc receptor modulating compounds and compositions
#415Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate
#416Modified antiviral peptides with increased activity and cell membrane affinity
#417Identification of n-alkylglycine trimers for induction of apoptosis
#418Therapeutic agents and methods of use thereof for the treatment of melanoma
#419Protein and its use in diagnosing Alzheimer's disease
#420Anti-cancer compounds
#421Irreversible cysteine protease inhibitors of legumain
#422Mass tags for quantitative analyses
#423Biologically active peptide conjugates
#424Oligopeptides, composition and use thereof as elicitors of the natural defences of plants
#425Targeted delivery to legumain-expressing cells
#426Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (iap)
#427Prodrugs built as multiple self-elimination-release spacers
#428Compounds for enzyme inhibition
#429Solid phase peptide synthesis of tri-peptide derivatives
#430Therapeutic agents and methods of use thereof for the modulation of angiogenesis
#431Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (IAP)
#432Neurotrophic and neuroprotective peptides
#433Reagents and methods for smooth muscle therapies
#434Hybrid molecules QA, wherein Q is an aminoquinoline and a is an antibiotic or a resistance enzyme inhibitor, their synthesis and their uses as antibacterial agent
#435Inhibitors of IAP
#436Immunoglobulin chimeric monomer-dimer hybrids
#437Thermostable and monoconjugatable gold cluster complexes
#438Di-, tri-, and tetra-peptides having antiangiogenic activity
#439Gene regulatory peptides
#440Coniosulfides and their derivatives, processes for preparing them, and their use as pharmaceuticals
#441Effectors of dipeptidyl peptidase IV for topical use
#442Selective substrates for matrix metalloproteinases
#443Macrocyclic hepatitis C serine protease inhibitors
#444Therapeutic agents and methods of use thereof for the modulation of angiogenesis
#445Peptide compositions for treatment of sexual dysfunction
#446Anti-fibril peptides
#447Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels
#448Peptides for enhanced cell attachment and growth
#449Antiarrhythmic peptides
#450Elastin peptide analogs and uses thereof
#451Methionine aminopeptidase-2 inhibitors and methods of use thereof
#452Elastin peptide analogs and uses thereof
#453Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
#454Methods and uses for protein breakdown products
#455Peptides for enhanced cell attachment and cell growth